Drugs modulating the levels of specific central neurotransmitters may influence both the rate and amount of functional recovery after focal brain injuries such as stroke. Because such drugs may be effective long after brain injury, the 'therapeutic window' may be widened beyond the first few hour after stroke and an entirely new avenue for pharmacological intervention may be possible. The impact of drugs affecting norepinephrine and γ-aminobutyric acid have been among the most extensively studied in the laboratory, and preliminary clinical data suggest similar effects in humans. Copyright (C) 1999.
|Number of pages||8|
|State||Published - Apr 2000|
ASJC Scopus subject areas
- Cellular and Molecular Neuroscience